Initial Companies Focused on Breakthrough Applications in Therapeutics, Agriculture, and Molecular Pathology
“The initial companies in our accelerator rose to the top of a highly competitive application process based on their potential to deliver innovative genomics apps in areas as diverse as healthcare and agriculture. Under Amanda’s leadership,
The Fall 2014 startups are focused on the following applications:
- Encoded Genomics, a biopharmaceutical company, is interrogating the human genome for functional elements with therapeutic properties.
- EpiBiome, an agriculture technology company, is developing bacteriophage compositions to prevent and treat mastitis infections in dairy cattle.
- Xcell Biosciences, a research tools and diagnostics company, is focused on commercializing its proprietary cell culture solution that enables researchers to easily grow primary cells from patient blood, including cancer and immune cells.
The Illumina Accelerator will provide selected startups with seed investment, business guidance, access to Illumina’s sequencing systems and reagents, and fully operational lab space in the
Applications for the Illumina Accelerator Spring 2015 funding cycle are due by
This release may contain forward looking statements that involve risks and uncertainties. Important factors that could cause actual results to differ materially from those in any forward-looking statements are detailed in our filings with the